Infinity Pharmaceuticals Inc (NASDAQ:INFI) Announces Q2 Results: Stock Jumps a Bit
Clinical stage biotech firm Infinity Pharmaceuticals Inc (NASDAQ:INFI) has been on the sights of investors over the course of the past week and during that period, the company’s stock has managed to clock gains of as much as 7%. However, at the same time, investors need to also remember that there has been no news about the company in the past week and the rally could also be speculative in…